|
|
Volumn 39, Issue 40, 2000, Pages 12262-12273
|
|
Evaluation of the effectiveness of DNA-binding drugs to inhibit transcription using the c-fos serum response element as a target
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CHROMOMYCIN A3;
HOE 33342;
NOGALAMYCIN;
SERUM RESPONSE FACTOR;
TRANSCRIPTION FACTOR;
ANIMAL CELL;
ARTICLE;
CELL FREE SYSTEM;
CELL STRAIN 3T3;
DRUG DNA BINDING;
EXCISION REPAIR;
GENE EXPRESSION;
MOUSE;
NONHUMAN;
ONCOGENE C FOS;
PRIORITY JOURNAL;
SERUM RESPONSIVE ELEMENT;
3T3 CELLS;
ANIMALS;
BENZIMIDAZOLES;
BINDING, COMPETITIVE;
BLOTTING, NORTHERN;
CELL-FREE SYSTEM;
CHROMOMYCIN A3;
DNA;
DNA-BINDING PROTEINS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ELECTROPHORESIS, POLYACRYLAMIDE GEL;
GENE EXPRESSION REGULATION;
MICE;
NOGALAMYCIN;
NUCLEAR PROTEINS;
PHARMACEUTICAL PREPARATIONS;
PROMOTER REGIONS (GENETICS);
PROTO-ONCOGENE PROTEINS C-FOS;
RESPONSE ELEMENTS;
RNA, MESSENGER;
SERUM RESPONSE FACTOR;
TIME FACTORS;
TRANSCRIPTION FACTORS;
TRANSCRIPTION, GENETIC;
|
|
EID: 0034633948
PISSN: 00062960
EISSN: None
Source Type: Journal
DOI: 10.1021/bi001427l Document Type: Article |
|
Times cited : (32)
|
|
References (44)
|
